Companies: 10,795·Total market cap: $144.5T
Mesoblast Limited

Mesoblast Limited

MESONASDAQHealthcare● Active
$13.80
$-0.15(-1.08%)
Market Cap$1.8B
P/E Ratio
52W High$21.5
52W Low$9.88
Overview

Mesoblast Limited (MESO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

meso · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
4
Sell
2
Strong Sell
0
Total: 11 · Buy rate: 45.5%

12-Month Price Target

High

$12.00

Consensus

$11.50

-16.7% upside

Low

$11.00

Median: $11.5 · Last Close: $13.80

The Mesoblast Limited (MESO) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month MESO price target is $11.50, representing -16.7% upside from the current price of $13.80.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $12 (-16.7%)

Consensus Target

$11.50

-16.7% upside

High Target

$12

-13.0%

Low Target

$11

-20.3%

Current Price

$13.80

as of today

Based on analyst price targets, the MESO stock price prediction for the next 12 months ranges from $11 to $12. The consensus MESO price forecast of $11.50 implies -16.7% upside from the current price of $13.80.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$13.581.57%

1-day model range: $13.52–$13.64. Peak: $13.64 (-1.57%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$16+16.2%
2028$17+26.5%
2029$18+32.7%
2030$19+36.3%
2031+38.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)40.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · MESO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$14.34SELL
MA 10$14.63SELL
MA 20$14.70SELL
MA 50$15.05SELL
MA 100$15.73SELL
MA 200$16.28SELL
Current $MESO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$14.27SELL
EMA 10$14.50SELL
EMA 20$14.72SELL
EMA 50$15.08SELL
EMA 100$15.50SELL
EMA 200$15.43SELL
Current $MESO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Jefferies2025-11-25
Upgrade ↑
HoldBuy
Jefferies2025-07-18
Downgrade ↓
BuyHold
Piper Sandler2025-02-07
Maintains
OverweightOverweight
Jefferies2024-12-23
Downgrade ↓
BuyHold
Piper Sandler2024-12-19
Maintains
OverweightOverweight
Piper Sandler2024-07-23
Upgrade ↑
NeutralOverweight
Cantor Fitzgerald2023-09-20
Maintains
OverweightOverweight
Jefferies2023-08-30
Upgrade ↑
HoldBuy
Cantor Fitzgerald2023-08-30
Maintains
OverweightOverweight
Maxim Group2023-08-06
Downgrade ↓
BuyHold

Wall Street analysts have recently issued updated ratings on Mesoblast Limited (MESO) stock. Of the recent 36 rating actions, 4 were upgrades and 12 were downgrades. 11 analysts currently cover MESO.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

MESO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$123M

↓ 59.2% YoY

Revenue Next Year

$200M

↑ 61.9% YoY

EPS This Year

$-0.34

EPS Next Year

$0.07

↓ 119.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MESO EPS of $-0.34 for the current fiscal year, based on estimates from 2 analysts. The MESO revenue forecast is $123M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The MESO stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MESO price target is $11.50 (-16.7% upside), with an analyst consensus of Buy.

The MESO short-term stock prediction for tomorrow is $13.58 (-1.57%). The MESO stock price prediction for 2027 estimates an average of $16. The MESO stock prediction for 2030 projects a range of $18–$20.

Mesoblast Limited trades on NASDAQ under the ticker MESO. The MESO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 45% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

MESO forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month MESO price target is $11.50, with a high forecast of $12.00 and a low of $11.00. The median price target is shown in the chart above when available. This implies -16.7% potential upside from the current price of $13.80.

MESO price targetWhat is MESO price targetMESO analyst price targetMESO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.